Princeton Global Asset Management LLC

Position in CRSP — CRISPR Therapeutics AG

CIK 1767349 PRINCETON, NJ

Position in CRSP

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$1,363

-$3,211 QoQ

Shares Held

-64.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#465

of 519 holders

Holding Since

Mar 2021

8 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Princeton Global Asset Management LLC holds $6,582,922 across 5 Biotechnology names. CRSP ranks #3 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	13,233	$6,573,228
2	ABCL	AbCellera Biologics Inc.	1,000	$7,850
3	CRSP	CRISPR Therapeutics AG This page	25	$1,363
4	MDXG	Mimedx Group, Inc.	100	$385
5	CTXR	Citius Pharmaceuticals, Inc.	160	$96

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,363	25	-64.3%	Shares	Sole	2026-07-16
2022-09-30	$4,574	70	0.0%	Shares	Sole	2022-11-14
2022-06-30	$4,253	70	0.0%	Shares	Sole	2022-08-04
2022-03-31	$4,393	70	-77.4%	Shares	Sole	2022-05-06
2021-12-31	$23,491	310	-92.6%	Shares	Sole	2022-02-02
2021-09-30	$471,113	4,209	-7.7%	Shares	Sole	2021-11-08
2021-06-30	$738,056	4,559	+6.0%	Shares	Sole	2021-08-04
2021-03-31	$523,955	4,300	—	Shares	Sole	2021-05-11
No filing history on record for this holder in this stock.